Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Imaging outcomes for trials of remyelination in multiple sclerosis.
Signal Transduction in the Blood-Brain Barriers
A 5-Year Follow-up of Rituximab Treatment in Patients With Neuromyelitis Optica Spectrum Disorder.
High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series.
Treatment of neuromyelitis optica.
Prevention and treatment of MS: studying the effects of vitamin D.
B-07The Cognitive Health Questionnaire: Initial Psychometric Data in a Multisite Multiple Sclerosis Sample.
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
Stress signaling etches heritable marks on chromatin.
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Disease-modifying treatments for progressive multiple sclerosis.
Laquinimod in multiple sclerosis.
BTG Commences Phase IIa Study of Multiple Sclerosis
Effect of Treatment Regimen on the Immunogenicity of Human Interferon Beta in Immune Tolerant Mice.
Embryonic stem cell lines derived from human blastocysts.
Application of fullerenes in nanomedicine: an update.
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
Identification of Selective Inhibitors of the Potassium Channel Kv1.1-1.2((3)) by High-Throughput Virtual Screening and Automated Patch Clamp.
Treatment of acute transverse myelitis and its early complications.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Pages

« first
‹ previous
…
124
125
126
127
128
129
130
131
132
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By